Use Patient-Centered Focus to Boost Trial Recruitment, Hamburg Says
Sponsors should increase use of patient-centered research because it can help them recruit more trial participants and better understand how a drug affects different patient groups, FDA Commissioner Margaret Hamburg and other experts say.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.